tradingkey.logo
Markets
News
Analysis
Tools
Learn
Stock Score
Stock Score
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo

Zenas Biopharma Inc

ZBIO
42.490USD
-0.680-1.58%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.79BMarket Cap
LossP/E TTM

Zenas Biopharma Inc

42.490
-0.680-1.58%
OverviewCompanyFinancialsAnalysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Zenas Biopharma Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-32.41%-41.13M
-34.83%-41.74M
-93.96%-37.05M
-150.35%-38.55M
-197.53%-31.06M
-48.04%-30.96M
26.71%-19.10M
10.08%-15.40M
--31.85M
---20.91M
---26.06M
---17.13M
Net income from continuing operations
-33.39%-51.50M
-37.51%-52.22M
-20.77%-33.57M
-113.95%-52.60M
-208.43%-38.61M
-30.74%-37.98M
-45.57%-27.80M
-29.45%-24.59M
--35.61M
---29.05M
---19.10M
---18.99M
Operating gains losses
-69.44%11.00K
-65.71%12.00K
-30.30%23.00K
10.00%33.00K
38.46%36.00K
20.69%35.00K
17.86%33.00K
20.00%30.00K
--26.00K
--29.00K
--28.00K
--25.00K
Other non-cash items
3909.60%5.01M
-628.78%-735.00K
-185.53%-136.00K
-321.94%-344.00K
-27.75%125.00K
-98.64%139.00K
-16.75%159.00K
-49.84%155.00K
--173.00K
--10.21M
--191.00K
--309.00K
Change in working capital
-180.63%-3.66M
0.04%5.16M
-229.03%-8.86M
17.17%8.87M
191.54%4.54M
286.14%5.16M
187.21%6.87M
508.28%7.57M
---4.96M
---2.77M
---7.87M
--1.24M
-Change in prepaid expenses
-189.44%-1.60M
137.23%1.16M
-119.75%-353.00K
-698.97%-8.18M
159.33%1.79M
-286.78%-3.10M
299.66%1.79M
100.74%1.36M
---3.02M
---802.00K
---895.00K
--680.00K
-Change in other current liabilities
----
----
----
----
---530.00K
---970.00K
--1.50M
----
----
--0.00
--0.00
----
Cash from non-recurring investing activities
Cash from operating activities
-32.41%-41.13M
-34.83%-41.74M
-93.96%-37.05M
-150.35%-38.55M
-197.53%-31.06M
-48.04%-30.96M
26.71%-19.10M
10.08%-15.40M
--31.85M
---20.91M
---26.06M
---17.13M
Investing cash flow
Net cash from continuing investing activities
--5.00M
-100.00%0.00
-18.18%18.00K
335.29%74.00K
--0.00
--35.00K
--22.00K
-98.42%17.00K
--0.00
--0.00
--0.00
--1.07M
Capital expenditures
--5.00M
-100.00%0.00
-18.18%18.00K
335.29%74.00K
--0.00
--35.00K
--22.00K
-98.42%17.00K
--0.00
--0.00
--0.00
--1.07M
Net cash flow from disposal of fixed assets
--0.00
-100.00%0.00
-18.18%18.00K
335.29%74.00K
--0.00
--35.00K
--22.00K
-77.03%17.00K
--0.00
--0.00
--0.00
--74.00K
Net cash flow from intangible asset transactions
--5.00M
----
----
----
----
----
----
-100.00%0.00
----
----
----
--1.00M
Net cash flow from investment products
268.32%45.04M
---112.29M
---86.26M
---3.66M
---26.76M
----
----
----
----
----
----
----
Net cash flow from other investing activities
--99.24M
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
249.64%40.04M
-320731.43%-112.29M
-392054.55%-86.27M
-21870.59%-3.73M
---26.76M
---35.00K
---22.00K
98.42%-17.00K
--0.00
--0.00
--0.00
---1.07M
Financing cash flow
Cash flow from continuous financing activities
-68.96%72.62M
-99.03%1.72M
116.12%99.00K
3606.00%1.85M
1069.90%233.98M
1615709.09%177.74M
-1216.36%-614.00K
-99.92%50.00K
--20.00M
--11.00K
--55.00K
--59.39M
Net cash flow from debt Issuance/repayment
--75.00M
----
----
----
-100.00%0.00
----
----
--0.00
--20.00M
----
----
--0.00
Net cash flow from common stock issuance/repurchase
-99.88%276.00K
----
----
--6.25M
--234.39M
----
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
--0.00
--0.00
--178.38M
----
----
--0.00
----
----
--59.39M
Proceeds from stock option exercised by employees
1975.00%664.00K
1288.71%1.72M
135.71%99.00K
54.00%77.00K
--32.00K
1027.27%124.00K
-23.64%42.00K
--50.00K
--0.00
--11.00K
--55.00K
--0.00
Net cash flow from other financing activities
-657.18%-3.32M
----
----
---4.47M
---439.00K
---766.00K
---656.00K
----
--0.00
--0.00
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-68.96%72.62M
-99.03%1.72M
116.12%99.00K
3606.00%1.85M
1069.90%233.98M
1615709.09%177.74M
-1216.36%-614.00K
-99.92%50.00K
--20.00M
--11.00K
--55.00K
--59.39M
Net cash flow
Beginning cash balance
-76.09%44.01M
427.79%196.55M
461.68%319.83M
397.43%360.13M
795.60%184.02M
-9.79%37.24M
-15.38%56.94M
177.52%72.40M
--20.55M
--41.28M
--67.30M
--26.09M
Current period cash flow changes
-59.37%71.56M
-203.93%-152.55M
-525.71%-123.28M
-160.74%-40.30M
239.65%176.11M
807.87%146.78M
24.26%-19.70M
-137.50%-15.45M
--51.85M
---20.73M
---26.01M
--41.21M
Effect of exchange rate changes
148.08%25.00K
-837.50%-236.00K
-244.44%-52.00K
262.07%141.00K
-1400.00%-52.00K
-80.72%32.00K
820.00%36.00K
-583.33%-87.00K
--4.00K
--166.00K
---5.00K
--18.00K
Ending cash balance
-67.91%115.56M
-76.09%44.01M
427.80%196.55M
461.67%319.83M
397.43%360.13M
795.60%184.02M
-9.79%37.24M
-15.38%56.94M
--72.40M
--20.55M
--41.28M
--67.30M
Free cash flow
-48.51%-46.13M
-34.68%-41.74M
-93.83%-37.07M
-150.55%-38.63M
-197.53%-31.06M
-48.21%-30.99M
26.62%-19.12M
15.30%-15.42M
--31.85M
---20.91M
---26.06M
---18.20M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI